T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Pugh, Siân A ^a   Harrison, Rebecca J ^a   Primrose, John N ^a   Khakoo, Salim I ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Adaptive immunity; Colorectal cancer; Colorectal liver metastases; Innate immunity; Natural killer cells; T cells

Indexed keywords

CD56 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM SURVIVAL; LYMPHOCYTIC INFILTRATION; MALE; NATURAL KILLER CELL; OVERALL SURVIVAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; CANCER SURGERY; CANCER SURVIVAL; LYMPHOCYTE COUNT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 84899091942     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-180     Document Type: Article

References (28)

1. Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012, 4:283-301. 3496330, 23152705.
2. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006, 13(10):1261-1268. 10.1245/s10434-006-9023-y, 16947009.
3. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008, 247(1):125-135. 10.1097/SLA.0b013e31815aa2c2, 18156932.
4. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313(5795):1960-1964. 10.1126/science.1129139, 17008531.
5. Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Lancet Oncol 2009, 10(9):877-884. 10.1016/S1470-2045(09)70186-X, 19656725.
6. Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology 2009, 137(4):1270-1279. 10.1053/j.gastro.2009.06.053, 2873775, 19577568.
7. Kumar S, Chang EY, Frankhouse J, Dorsey PB, Lee RG, Johnson N. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator for adjuvant therapy in colon cancer. Arch Surg 2009, 144(9):835-840. 10.1001/archsurg.2009.162, 19797108.
8. Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009, 27(35):5944-5951. 10.1200/JCO.2008.19.6147, 19858404.
9. Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, Jarnagin W, Fong Y, Blumgart L, D'Angelica M, DeMatteo RP. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol 2009, 16(9):2524-2530. 10.1245/s10434-009-0585-3, 19568816.
10. Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol 2013, 20(3):946-955. 10.1245/s10434-012-2668-9, 3740360, 23010736.
11. Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009, 27(2):186-192. 10.1200/JCO.2008.18.7229, 19064967.
12. Mackay IR. Hepatoimmunology: a perspective. Immunol Cell Biol 2002, 80(1):36-44. 10.1046/j.1440-1711.2002.01063.x, 11869361.
13. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000, 174:5-20. 10.1034/j.1600-0528.2002.017416.x, 10807503.
14. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. The human liver contains multiple populations of NK cells, T cells, and CD3 + CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999, 163(4):2314-2321.
15. Norris S, Doherty DG, Collins C, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum Immunol 1999, 60(1):20-31. 10.1016/S0198-8859(98)00098-6, 9952024.
16. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Natural killer activity of human liver-derived lymphocytes in various liver diseases. Hepatology 1991, 14(3):495-503. 10.1002/hep.1840140315, 1874494.
17. Lodoen MB, Lanier LL. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 2006, 18(4):391-398. 10.1016/j.coi.2006.05.002, 16765573.
18. Adams DH, Eksteen B, Curbishley SM. Immunology of the gut and liver: a love/hate relationship. Gut 2008, 57(6):838-848. 10.1136/gut.2007.122168, 18203807.
19. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3(1):51-62. 10.1038/nri981, 12511875.
20. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, Davies DA. Induction of immunological tolerance by porcine liver allografts. Nature 1969, 223(5205):472-476. 10.1038/223472a0, 4894426.
21. Curry MP, Norris S, Golden-Mason L, Doherty DG, Deignan T, Collins C, Traynor O, McEntee GP, Hegarty JE, O'Farrelly C. Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization. J Immunol Methods 2000, 242(1-2):21-31.
22. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001, 14(2):123-133. 10.1016/S1074-7613(01)00095-4, 11239445.
23. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002, 419(6908):734-738. 10.1038/nature01112, 12384702.
24. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
25. Kenna T, Golden-Mason L, Porcelli SA, Koezuka Y, Hegarty JE, O'Farrelly C, Doherty DG. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 2003, 171(4):1775-1779.
26. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012, 481(7381):394-398.
27. Peppa D, Gill US, Reynolds G, Easom NJ, Pallett LJ, Schurich A, Micco L, Nebbia G, Singh HD, Adams DH, Kennedy PT, Maini MK. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 2013, 210(1):99-114. 10.1084/jem.20121172, 3549717, 23254287.
28. Lassen MG, Lukens JR, Dolina JS, Brown MG, Hahn YS. Intrahepatic IL-10 maintains NKG2A + Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol 2010, 184(5):2693-2701. 10.4049/jimmunol.0901362, 2885840, 20124099.